H. C. S. Howlett

Statistics

Publications

Citations

409

H-Index

Active since

1975

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Serono Ltd. (United Kingdom)

Merck Serono S.A.S. (France)

Inserm

Aston University

H. C. S. Howlett is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, diabetes management, and diabetes mellitus.

Publications per year

1975–2006

Publications

Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance<sup>®</sup>) in Type 2 diabetic patients inadequately controlled on metformin

Michel Marre, H. C. S. Howlett, P. Lehert et al. · Diabetic Medicine · 2002 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +17

THE SECCAT SURVEY: I. THE COSTS AND CONSEQUENCES OF ALCOHOLISM

Malachi J. McKenna, Jonathan Chick, Martin Buxton et al. · Alcohol and Alcoholism · 1996 · 70 citations · Full text

Nursing, Pharmacoeconomics, Cost-effectiveness Analysis +15

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

Differential effects of metformin on bile salt absorption from the jejunum and ileum

D. Carter, H. C. S. Howlett, Nicolas Wiernsperger et al. · Diabetes Obesity and Metabolism · 2003 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

New prolonged-release metformin improves gastrointestinal tolerability

Jaime A. Davidson, H. C. S. Howlett · The British Journal of Diabetes · 2004 · 39 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 10